These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12740633)

  • 1. Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys.
    Wilkins C; Bhatta K; Pledger M; Casswell S
    N Z Med J; 2003 Apr; 116(1171):U383. PubMed ID: 12740633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emergence of amphetamine use in New Zealand: findings from the 1998 and 2001 National Drug Surveys.
    Wilkins C; Bhatta K; Casswell S;
    N Z Med J; 2002 Nov; 115(1166):U256. PubMed ID: 12552272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent population trends in amphetamine use in New Zealand: comparisons of findings from national household drug surveying in 1998, 2001, and 2003.
    Wilkins C; Sweetsur P; Casswell S
    N Z Med J; 2006 Oct; 119(1244):U2285. PubMed ID: 17072360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
    Wilkins C; Sweetsur P
    N Z Med J; 2008 May; 121(1274):61-71. PubMed ID: 18535647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marijuana use in New Zealand, 1990 and 1998.
    Field A; Casswell S
    N Z Med J; 2001 Aug; 114(1137):355-8. PubMed ID: 11587304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of amphetamine use in New Zealand: findings from the 2001 National Drug Survey.
    Wilkins C; Pledger M; Bhatta K; Casswell S
    N Z Med J; 2004 Mar; 117(1190):U796. PubMed ID: 15107899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criminal involvement among young male ecstasy users.
    Hendrickson JC; Gerstein DR
    Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA; Rosenberg H
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females.
    Cance JD; Ashley OS; Penne MA
    J Adolesc Health; 2005 Nov; 37(5):409. PubMed ID: 16227128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending drug ethno-epidemiology using agent-based modelling.
    Moore D; Dray A; Green R; Hudson SL; Jenkinson R; Siokou C; Perez P; Bammer G; Maher L; Dietze P
    Addiction; 2009 Dec; 104(12):1991-7. PubMed ID: 19804460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol use and risk taking among regular ecstasy users.
    Breen C; Degenhardt L; Kinner S; Bruno R; Jenkinson R; Matthews A; Newman J
    Subst Use Misuse; 2006; 41(8):1095-109. PubMed ID: 16798678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can the severity of dependence scale be usefully applied to 'ecstasy'?
    Bruno R; Matthews AJ; Topp L; Degenhardt L; Gomez R; Dunn M
    Neuropsychobiology; 2009; 60(3-4):137-47. PubMed ID: 19893331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study.
    Carhart-Harris RL; Nutt DJ; Munafò M; Wilson SJ
    J Psychopharmacol; 2009 May; 23(3):249-57. PubMed ID: 18562419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.